292 related articles for article (PubMed ID: 29104726)
21. miR-27a promotes cell proliferation and metastasis in renal cell carcinoma.
Peng H; Wang X; Zhang P; Sun T; Ren X; Xia Z
Int J Clin Exp Pathol; 2015; 8(2):2259-66. PubMed ID: 25973137
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-200a-3p suppresses tumor proliferation and induces apoptosis by targeting SPAG9 in renal cell carcinoma.
Wang X; Jiang F; Song H; Li X; Xian J; Gu X
Biochem Biophys Res Commun; 2016 Feb; 470(3):620-626. PubMed ID: 26797273
[TBL] [Abstract][Full Text] [Related]
23. Downregulated microRNA-510-5p acts as a tumor suppressor in renal cell carcinoma.
Chen D; Li Y; Yu Z; Li Y; Su Z; Ni L; Yang S; Gui Y; Lai Y
Mol Med Rep; 2015 Aug; 12(2):3061-6. PubMed ID: 25936999
[TBL] [Abstract][Full Text] [Related]
24. Tumor suppressor miR-149-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.
Jin L; Li Y; Liu J; Yang S; Gui Y; Mao X; Nie G; Lai Y
Mol Med Rep; 2016 Jun; 13(6):5386-92. PubMed ID: 27121091
[TBL] [Abstract][Full Text] [Related]
25. The IGF-I/JAK2-STAT3/miR-21 signaling pathway may be associated with human renal cell carcinoma cell growth.
Su Y; Zhao A; Cheng G; Xu J; Ji E; Sun W
Cancer Biomark; 2017 Jul; 19(3):289-296. PubMed ID: 28453463
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of microRNA-100 predicts an unfavorable prognosis in renal cell carcinoma.
Wang G; Chen L; Meng J; Chen M; Zhuang L; Zhang L
Int Urol Nephrol; 2013 Apr; 45(2):373-9. PubMed ID: 23378187
[TBL] [Abstract][Full Text] [Related]
27. MiRNA-200a induce cell apoptosis in renal cell carcinoma by directly targeting SIRT1.
Fu H; Song W; Chen X; Guo T; Duan B; Wang X; Tang Y; Huang L; Zhang C
Mol Cell Biochem; 2018 Jan; 437(1-2):143-152. PubMed ID: 28717923
[TBL] [Abstract][Full Text] [Related]
28. Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.
Okato A; Arai T; Yamada Y; Sugawara S; Koshizuka K; Fujimura L; Kurozumi A; Kato M; Kojima S; Naya Y; Ichikawa T; Seki N
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902136
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of miR-21 expression is a valuable predicator of advanced clinicopathological features and poor prognosis in patients with renal cell carcinoma through the p53/p21‑cyclin E2‑Bax/caspase-3 signaling pathway.
Liu Z; Lu Y; Xiao Y; Lu Y
Oncol Rep; 2017 Mar; 37(3):1437-1444. PubMed ID: 28184919
[TBL] [Abstract][Full Text] [Related]
30. Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma.
Zhai Q; Zhou L; Zhao C; Wan J; Yu Z; Guo X; Qin J; Chen J; Lu R
Biochem Biophys Res Commun; 2012 Mar; 419(4):621-6. PubMed ID: 22369946
[TBL] [Abstract][Full Text] [Related]
31. Tumor suppressive miR-196a is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.
Li Y; Jin L; Chen D; Liu J; Su Z; Yang S; Gui Y; Mao X; Nie G; Lai Y
Mol Med Rep; 2016 Jul; 14(1):560-6. PubMed ID: 27175581
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of OCLN and GAS1 in clear cell renal cell carcinoma.
Conceição AL; Da Silva CT; Badial RM; Valsechi MC; Stuqui B; Gonçalves JD; Jasiulionis MG; De Freitas Calmon M; Rahal P
Oncol Rep; 2017 Mar; 37(3):1487-1496. PubMed ID: 28184927
[TBL] [Abstract][Full Text] [Related]
33. Identification of miR‑130b as an oncogene in renal cell carcinoma.
Li Y; Chen D; Li Y; Jin L; Liu J; Su Z; Qi Z; Shi M; Jiang Z; Gui Y; Yang S; Mao X; Lai Y
Mol Med Rep; 2016 Feb; 13(2):1902-8. PubMed ID: 26717956
[TBL] [Abstract][Full Text] [Related]
34. Upregulated microRNA-16 as an oncogene in renal cell carcinoma.
Chen D; Li Y; Yu Z; Su Z; Yu W; Li Y; Yang S; Gui Y; Ni L; Lai Y
Mol Med Rep; 2015 Jul; 12(1):1399-404. PubMed ID: 25815587
[TBL] [Abstract][Full Text] [Related]
35. Mechanism and function of decreased FOXO1 in renal cell carcinoma.
Zhou L; Yin B; Liu Y; Hong Y; Zhang C; Fan J
J Surg Oncol; 2012 Jun; 105(8):841-7. PubMed ID: 22213032
[TBL] [Abstract][Full Text] [Related]
36. microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.
Yoshino H; Yonemori M; Miyamoto K; Tatarano S; Kofuji S; Nohata N; Nakagawa M; Enokida H
Oncotarget; 2017 Mar; 8(13):20881-20894. PubMed ID: 28152509
[TBL] [Abstract][Full Text] [Related]
37. miR-144-3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting MAP3K8.
Liu F; Chen N; Xiao R; Wang W; Pan Z
Biochem Biophys Res Commun; 2016 Nov; 480(1):87-93. PubMed ID: 27717821
[TBL] [Abstract][Full Text] [Related]
38. Reduced L/B/K alkaline phosphatase gene expression in renal cell carcinoma: plausible role in tumorigenesis.
Sharma U; Pal D; Singh SK; Kakkar N; Prasad R
Biochimie; 2014 Sep; 104():27-35. PubMed ID: 24909115
[TBL] [Abstract][Full Text] [Related]
39. Expression Profiles and Clinical Significance of MicroRNAs in Papillary Renal Cell Carcinoma: A STROBE-Compliant Observational Study.
Ge YZ; Xu LW; Xu Z; Wu R; Xin H; Zhu M; Lu TZ; Geng LG; Liu H; Zhou CC; Yu P; Zhao YC; Hu ZK; Zhao Y; Zhou LH; Wu JP; Li WC; Zhu JG; Jia RP
Medicine (Baltimore); 2015 Apr; 94(16):e767. PubMed ID: 25906110
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA‑24‑2 is associated with cell proliferation, invasion, migration and apoptosis in renal cell carcinoma.
Jin L; Li Y; Nie L; He T; Hu J; Liu J; Chen M; Shi M; Jiang Z; Gui Y; Yang S; Lai Y
Mol Med Rep; 2017 Dec; 16(6):9157-9164. PubMed ID: 28990105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
